Sarcoidosis following SARS-CoV-2 infection: Cause or consequence?

Respirol Case Rep. 2022 Apr 27;10(6):e0955. doi: 10.1002/rcr2.955. eCollection 2022 Jun.

Abstract

The COVID-19 pandemic has been a worldwide medical challenge. Despite rapid advancements, many questions regarding SARS-CoV-2 interaction with other pathologies and long-term consequences remained unanswered. Sarcoidosis is a multi-systemic granulomatous disease that develops in genetically predisposed individuals following their exposure to an environmental trigger. We present the case of a patient who was diagnosed with sarcoidosis following a SARS-CoV-2 infection.

Keywords: COVID‐19; SARS‐CoV‐2; sarcoidosis.

Publication types

  • Case Reports